The Global Gastrointestinal Endoscopy Market size was valued at US$ 14.09 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030. A gastrointestinal endoscopy, also known as gastroscopy or digestive endoscopy, is a diagnostic and therapeutic procedure for illnesses of the upper digestive tract. The oesophagus, stomach, and duodenum form the upper digestive system (the first part of the small intestine). The endoscope device is introduced through the mouth, and the acquired images are presented on the monitor in real-time and/or recorded as the endoscope moves through the body. Endoscopy is occasionally performed with other procedures, such as an ultrasound. Attaching an ultrasound probe to the endoscope creates images of the oesophagus or stomach wall. Endoscopic ultrasound can also be used to create images of inaccessible organs, such as the pancreatic. Newer endoscopes utilise high-definition video to provide images with greater clarity. Numerous endoscopes employ a narrow band imaging technology that uses specialised light to improve the detection of precancerous diseases like Barrett's oesophagus. Modern endoscopy has shown to be immensely valuable in many fields of medicine because it entails relatively few risks, produces detailed images, and is rapid to do.
The gastrointestinal endoscopy market will be driven by factors such as an increasing need for endoscopy, the progress of new technologies, an increase in investments and funding, an increasing number of cases of gastrGlobal Gastrointestinal Endoscopy Market ointestinal illnesses, and increasing demand for procedures that are minimally invasive. Also, new device approvals will play an essential role in developing gastrointestinal endoscopy. In Feb 2022, Ambu announced that the FDA had approved their Ambu® aScopeTM Gastro and Ambu® aBoxTM 2 Single-Use Gastroscope and Next-Generation Display Unit. Ambu's solution addresses the current drawbacks of reusable endoscopes with advanced technology, portability, and cost-effectiveness, making it a suitable alternative for customers looking to perform gastroscopies in a variety of care settings (including endoscopy unit, OR, ICU, ER, ASC).
However, the high cost of endoscopic operations, adverse healthcare development, and limited reimbursement will hinder the growth of the market for gastrointestinal endoscopy. However, the expanding healthcare market in emerging nations and the development of gastrointestinal endoscopic devices will create several growth prospects for the gastrointestinal endoscopy market throughout the forecasting period.
The Gastrointestinal Endoscopy Market is segmented into two major segments Types and End-User. By type, the market is widely classified. First is Gastrointestinal Endotherapy, which includes ERCP Devices, Gastrointestinal Stents, Balloon Dilators, Ultrasound Endoscopes, Biopsy Devices, Hemostasis Devices, Retrieval Devices, and Others. The gastrointestinal Stents category is subdivided into Esophageal Stents, Biliary Stents, and Pancreatic Stents. In comparison, the Biopsy Devices category is again divided into Biopsy Forceps, Polypectomy Snares, and Other Biopsy Devices. The second is Gastrointestinal Endoscopes and Endoscopic Systems, which contains three sub-divisions: Gastrointestinal Videoscopes, Visualization Systems, and Capsule Endoscopes. The sub-division Gastrointestinal Videoscopes comprises Gastroscopes, Colonoscopes, Duodenoscopes, Sigmoidoscopes, Enteroscopes and Anoscopes. The second significant segment, the End-User segment, includes, Hospitals, Ambulatory Surgery Centers, and Others.
In 2021, North America dominated the market. The introduction of new endoscopic devices will fuel market growth in North America. In addition, the increased prevalence of gastrointestinal illnesses, cancer, and other chronic conditions, as well as the rising desire for minimally invasive procedures, will increase North America's global market share.
The Gastrointestinal Endoscopy Market players are Boston Scientific Corporation, Medtronic plc, KARL STORZ SE & Co. KG, Ambu A/S, Teleflex Incorporated, HOYA Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Cook Group Inc, SonoScape Medical Corp., EndoMed Systems GmbH, CapsoVision, Inc., HuiZhou Xzing Technology Co., Ltd., Endogene Ltd., Envaste Limited and other prominent players of the market.
- Boston Scientific Corporation
- Medtronic plc
- KARL STORZ SE & Co. KG
- Ambu A/S
- Teleflex Incorporated
- HOYA Corporation
- Olympus Corporation
- FUJIFILM Holdings Corporation
- Cook Group Inc
- SonoScape Medical Corp.
- EndoMed Systems GmbH
- CapsoVision, Inc.
- HuiZhou Xzing Technology Co., Ltd.
- Endogene Ltd.
- Envaste Limited